The burden of poor glycaemic control in people with newly diagnosed type 2 diabetes in Sweden: A health economic modelling analysis based on nationwide data.
Margareta HellgrenAnn-Marie SvenssonStefan FranzénÅsa EricssonSoffia GudbjörnsdottirNils EkströmRebecka BertilssonWilliam ValentineSamuel Joseph Paul MalkinPublished in: Diabetes, obesity & metabolism (2021)
Even in people with T2D initiating first-line glucose-lowering therapy, the economic burden of poor glycaemic control in Sweden is substantial, but could be reduced by early and effective treatment to achieve glycaemic targets.
Keyphrases
- type diabetes
- newly diagnosed
- glycemic control
- healthcare
- cardiovascular disease
- insulin resistance
- mental health
- electronic health record
- blood glucose
- stem cells
- risk factors
- health information
- adipose tissue
- mesenchymal stem cells
- machine learning
- health promotion
- risk assessment
- combination therapy
- climate change
- weight loss